Amgen Inc. (AMGN) announced after the close Thursday that the U.S. District Court in Delaware granted the company's request for a permanent injunction prohibiting Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) from infringing two patents that Amgen holds for Repatha.
from RTT - Hot Stocks http://ift.tt/2ik2neQ
via IFTTT
No comments:
Post a Comment